Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion

被引:81
作者
Orth, B
Frei, R
Itin, PH
Rinaldi, MG
Speck, B
Gratwohl, A
Widmer, AF
机构
[1] UNIV BASEL HOSP, DIV CLIN EPIDEMIOL, CH-4031 BASEL, SWITZERLAND
[2] UNIV BASEL HOSP, DEPT LAB MED, BACTERIOL LAB, CH-4031 BASEL, SWITZERLAND
[3] UNIV BASEL HOSP, DEPT DERMATOL, CH-4031 BASEL, SWITZERLAND
[4] UNIV BASEL HOSP, DIV HEMATOL, CH-4031 BASEL, SWITZERLAND
[5] UNIV BASEL HOSP, DIV CLIN EPIDEMIOL, CH-4031 BASEL, SWITZERLAND
[6] UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA
关键词
Paecilomyces lilacinus; mycoses; immunocompromised host; opportunistic infections;
D O I
10.7326/0003-4819-125-10-199611150-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Invasive mycoses are an important cause of illness and death in immunocompromised patients. Infections with molds other than aspergilli have been increasingly seen in patients with hematologic cancers, but epidemics of these infections have not yet been reported. Objective: To describe an outbreak of invasive mycoses with Paecilomyces lilacinus in severely neutropenic patients. Design: An outbreak investigation. Setting: The hematology-oncology isolation and bone marrow transplantation unit of the University Hospital, Basel, Switzerland. Patients: 25 consecutive patients admitted between 17 August 1993 (the date of the first manifestation of P. lilacinus infection) and 31 October 1993 (when the unit was closed). Measurements: Clinical and microbiological data, including histologic findings; cultures from several patient sites; and environmental examinations of potential airborne, parenteral, enteric, and horizontal routes of transmission. Infections were defined by the isolation of P. lilacinus from clinically evident skin eruptions. Results: 12 of the 25 patients (48%) were infected or colonized. Nine patients (36%), including all bone marrow transplant recipients, had documented invasive P. lilacinus infections. All 9 infected patients had papular, pustular, or necrotic skin eruptions. Two patients with severe graft-versus-host disease died with refractory fungal disease; 1 also had microbiologically documented endophthalmitis and kidney infiltrates. Seven affected patients no longer had P. lilacinus after recovery of bone marrow function. The organism was resistant in vitro to amphotericin B, itraconazole, and fluconazole. Patients did not respond clinically to these agents. The outbreak was ultimately traced to a contaminated, commercially available, pharmaceutically prepared skin lotion. The outbreak ended after the skin lotion was recalled and has not recurred after a follow-up period of 2 years. Conclusion: Contaminated skin lotion is a potential cause of opportunistic fungal infections in immunocompromised hosts. Paecilomyces lilacinus is a common saprophytic mold that can cause, by direct cutaneous inoculation, invasive infections associated with illness and death.
引用
收藏
页码:799 / +
页数:1
相关论文
共 33 条
[1]  
ABDELHAFEZ AII, 1990, J BASIC MICROB, V30, P3
[2]   OPPORTUNISTIC MYCOSES IN THE IMMUNOCOMPROMISED HOST - EXPERIENCE AT A CANCER CENTER AND REVIEW [J].
ANAISSIE, E .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S43-S53
[3]   PRIMARY CUTANEOUS FUNGAL INFECTION AFTER SOLID-ORGAN TRANSPLANTATION - REPORT OF 5 CASES AND REVIEW [J].
BENEDICT, LM ;
KUSNE, S ;
TORRECISNEROS, J ;
HUNT, SJ .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :17-21
[4]  
Bernacer M., 1992, Medical Microbiology Letters, V1, P207
[5]   ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUVANT THERAPY FOR FUNGAL INFECTION IN PATIENTS WITH CANCER [J].
BODEY, GP ;
ANAISSIE, E ;
GUTTERMAN, J ;
VADHANRAJ, S .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) :705-707
[6]  
CASTRO LGM, 1990, J MED VET MYCOL, V28, P15
[7]   REMOVAL OF NOSOCOMIAL PATHOGENS FROM THE CONTAMINATED GLOVE - IMPLICATIONS FOR GLOVE REUSE AND HANDWASHING [J].
DOEBBELING, BN ;
PFALLER, MA ;
HOUSTON, AK ;
WENZEL, RP .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (05) :394-398
[8]   COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI [J].
ESPINELINGROFF, A ;
DAWSON, K ;
PFALLER, M ;
ANAISSIE, E ;
BRESLIN, B ;
DIXON, D ;
FOTHERGILL, A ;
PAETZNICK, V ;
PETER, J ;
RINALDI, M ;
WALSH, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :314-319
[9]  
GORDON MA, 1984, SABOURAUDIA, V22, P109
[10]   PAECILOMYCES-LILACINUS CELLULITIS IN AN IMMUNOCOMPROMISED PATIENT [J].
JADE, KB ;
LYONS, MF ;
GNANN, JW .
ARCHIVES OF DERMATOLOGY, 1986, 122 (10) :1169-1170